HIV News and Research

RSS

Danish researchers take an important step in finding a cure for HIV

For around 40 years, scientists all over the world have been unsuccessfully trying to find a cure for HIV, but now a team of researchers from Aarhus University and Aarhus University Hospital have apparently found an important element in the equation.

17 Oct 2022

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

Researchers presented an overview of factors influencing emerging infectious diseases. They also highlighted the importance of molecular dynamic (MD) simulations and molecular docking (MDO) analysis for combating these diseases.

17 Oct 2022

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

In a recent study published in the International Journal of Infectious Diseases, researchers assessed the efficacy of coronavirus disease 2019 (COVID-19) vaccines in people living with human immunodeficiency virus (HIV).

16 Oct 2022

Intimate partner violence common and chronic among young sexual, gender minorities assigned male at birth

Intimate partner violence is chronic among young sexual and gender minorities assigned male at birth (YSGM-AMAB), with bisexual, transgender and lower-income people in this group having the highest likelihood of victimization, a Rutgers study has found.

14 Oct 2022

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

13 Oct 2022

Novel testing method could simplify widespread tuberculosis screening

Tuberculosis can be tough to detect. Diagnosis usually requires coughing up a sputum sample from the lungs, which can be unpleasant, impractical, and even hazardous.

13 Oct 2022

Poll shows high interest, uneven use of direct-to-consumer medical tests

Kitchen counters and bathroom sinks across America turned into miniature medical testing labs over the past year, as millions of people swabbed their noses and found out in minutes if they had COVID-19.

13 Oct 2022

Research project on female schistosomiasis receives record-high funding

Female genital schistosomiasis (FGS) is a disease that affects millions of women, but it is often misdiagnosed as cancer or a venereal disease. This leads to unnecessary surgery, social sanctions and ruined lives.

12 Oct 2022

Duke receives federal funding for HIV vaccine research

The Duke Human Vaccine Institute and the Department of Surgery at Duke University School of Medicine received a grant from the National Institute of Allergy and Infectious Diseases for HIV vaccine research that could total $25.9 million with full funding over five years.

11 Oct 2022

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteins

In a new study, researchers pursued direct-acting severe acute respiratory syndrome coronavirus-2 drugs that compete for nucleotide-binding pockets (NBPs) of SARS-CoV-2 proteins.

11 Oct 2022

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

Findings from a small study of eight patients published in Clinical Infectious Diseases suggest that COVID-19 rebound is likely not caused by impaired immune responses.

6 Oct 2022

The involvement of minor intron-containing gene-encoded proteins in viral infections

Researchers explored the role of the minor intron-containing gene (MIG)-encoded proteins (MIG-Ps) depending on minor spliceosome-MiG excision to be expressed in infections by pathogenic viruses.

6 Oct 2022

Did telehealth appointments improve HIV care retention during the COVID-19 pandemic?

In a new study, researchers assessed how measures of retention in human immunodeficiency virus (HIV) care have changed due to the COVID-19 pandemic.

6 Oct 2022

Vaccine hesitancy not the main barrier to immunization in low-income countries

Low vaccination rates in poorer countries have little to do with so-called “vaccine hesitancy” according to a study that examined access to COVID-19 tools across 14 low-income countries.

5 Oct 2022

Ongoing discrimination leads to a setback in prevention, treatment of AIDS

The world is losing the battle against AIDS due to ongoing discrimination around preventative medicines, testing and treatments, an international conference has been warned.

5 Oct 2022

Routine newborn screening for sickle cell disease urgently needed to save lives in Africa

More than 300,000 babies globally are born every year with sickle cell, a hereditary condition which causes red blood cells to become sickle-shaped.

5 Oct 2022

Myocarditis may be attributable to monkeypox infection

A new study published in Emerging Infectious Diseases found that myocardial infiltration could cause myocarditis during monkeypox virus infection.

5 Oct 2022

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

Researchers described the human monkeypox virus infection after vaccination with the modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine.

5 Oct 2022

NIH awards 103 new grants to support meritorious behavioral and biomedical research projects

The High-Risk, High-Reward Research program, supported by the Common Fund at the National Institutes of Health has awarded 103 new research grants to support highly innovative scientists who propose visionary and broadly impactful meritorious behavioral and biomedical research projects.

4 Oct 2022

Small antiviral molecules termed assembly modulators show therapeutic efficacy against cancer

In a new study, researchers evaluated the anti-cancer therapeutic efficacy of two structurally-unrelated small molecules, PAV-617 and PAV-951.

4 Oct 2022

HIV News and Research

Danish researchers take an important step in finding a cure for HIV

Exploring molecular docking and molecular dynamics simulations as advanced tools for novel antiviral drug discovery

COVID-19 vaccines show favorable immunogenicity and efficacy in people living with HIV

Intimate partner violence common and chronic among young sexual, gender minorities assigned male at birth

HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

Novel testing method could simplify widespread tuberculosis screening

Poll shows high interest, uneven use of direct-to-consumer medical tests

Research project on female schistosomiasis receives record-high funding

Duke receives federal funding for HIV vaccine research

Researchers explore drug-repurposing candidates acting against nucleotide-binding pockets of multiple SARS-CoV-2 proteins

Impaired immune responses not responsible for COVID-19 rebound, findings suggest

The involvement of minor intron-containing gene-encoded proteins in viral infections

Did telehealth appointments improve HIV care retention during the COVID-19 pandemic?

Vaccine hesitancy not the main barrier to immunization in low-income countries

Ongoing discrimination leads to a setback in prevention, treatment of AIDS

Routine newborn screening for sickle cell disease urgently needed to save lives in Africa

Myocarditis may be attributable to monkeypox infection

Study finds the majority of post-vaccination monkeypox infections occur within 2 weeks of receiving the first dose of MVA-BN

NIH awards 103 new grants to support meritorious behavioral and biomedical research projects

Small antiviral molecules termed assembly modulators show therapeutic efficacy against cancer

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News